跳至主要内容
临床试验/KCT0001381
KCT0001381已完成未知

The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial

Yuyu Phama0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 69(Year)(—)
性别
All

入选标准

  • 1. Patients diagnosed with sudden deafness
  • 2. Patients who visited the hospital within 1 week from the day of symptom onset
  • 3. Patients aged between 20 and 70
  • 4. Patients without a history of other treatments for hearing loss
  • 5. Patients who are available for a 28-day follow-up
  • 6. Patients who provided a voluntary written agreement for study participation

排除标准

  • 1. Patients with a severe renal, hepatic or respiratory disease
  • 2. Patients with heart failure
  • 3. Patients with a history of myocardial infarction within the previous 4 weeks
  • 4. Pregnancy, breast-feeding, or child-bearing potential
  • 5. Patients with known allergic reaction or adverse event to ginkgo leaf
  • 6. Patients with sudden deafness with rotatory vertigo
  • 7. Patients who had participated in another clinical trial of a drug or medical device within 30 days before screening
  • 8. Patients who are deemed not appropriate for participation on the study

研究者

发起方
Yuyu Phama

相似试验